← SynDRA
LOMEFLOXACIN
SynDRA canonical compound SYN0000840 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · OTC |
| Mechanism of action | bacterial DNA gyrase inhibitor |
| Indication | respiratory tract infections | urinary tract infections |
| Disease area | infectious disease |
All known targets
Mechanisms of action (all sources)
- DNA gyrase inhibitor
- Inhibitor
- gyrA INHIBITOR
- gyrB INHIBITOR
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
- Antineoplastic Agents
- Enzyme Inhibitors
- Topoisomerase II Inhibitors
- Topoisomerase Inhibitors
ATC classes
- J01M · QUINOLONE ANTIBACTERIALS
- S01A · ANTIINFECTIVES
Cross-references
Synonyms
- lomeflon
- lomefloxacin hydrochloride
- lomefloxacin HCl
- Lomefloxacine
- Lomefloxacino
- SC-47111A
- Okacyn
- LFLX
- Lomefloxacinum
- Lomefloxacine [French]
- Lomefloxacino [Spanish]
- Lomefloxacinum[Latin]
- SC-4711
- DM 10 (bactericide)
- DM-10
- Lomefloxacin (USAN)
- Maxaquin (TN)
- Maxaquin (hydrochloride)
- Okacyn (TN)
- Uniquin (TN)
- Lomefloxacin [USAN:BAN:INN]
- NY-198 (hydrochloride)
- SC-47111 (hydrochloride)
- SC-47111B (mesylate)
- (+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
- 1,4-Dihydro-6,8-difluoro-1-ethyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
- 1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid
- 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
- 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, monohydrochloride
- Lomefloxacinum [Latin]
- SC 47111A
- CHEBI:116278
- L6BR2WJD8V
- SC47111A
- 1-ethyl-6-fluoranyl-8-fluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid
- LOMEFLOXACIN [USAN]
- 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-
Look up LOMEFLOXACIN in the interactive SynDRA portal →